Introduction: built-in chromatographic, no cost payload, and cytotoxicity assays empower precise DAR characterization crucial to optimizing Secure and powerful antibody-drug conjugates in cancer therapy. while in the realm of specific cancer therapies, keeping rigorous high-quality specifications is vital, Specially regarding drug-to-antibody rati